Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

505
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
505
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

256
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
256

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Prediction Models for Psychological Distress in Patients With Malignant Tumors: A Scoping Review.

Psycho-oncology·2026
Same author

Hypoxia-preconditioned dental pulp stem cells alleviate acetaminophen-induced liver failure via promoting MYC-HIF1A/HIF-1α-BNIP3-mediated mitophagy.

Autophagy·2026
Same author

The role of extracellular matrix stiffness in regulating fibroblast behaviors and disease progression.

Frontiers in immunology·2026
Same author

Optimizing the osteo-immunomodulatory balance: threshold-saturation effects of BMP-2-loaded allografts in the Masquelet's induced membrane technique (MIMT).

Frontiers in bioengineering and biotechnology·2026
Same author

A coupled heat-cold island network framework for urban heat island mitigation: a case study of Central Fuzhou.

Scientific reports·2026
Same author

2-Hydroxyisobutyrylation and Phosphorylation Crosstalk Guides Metastasis Prediction and Immunotherapy in Esophageal Squamous Cell Carcinoma.

MedComm·2026

相关实验视频

Updated: Sep 10, 2025

Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation
09:53

Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation

Published on: January 10, 2025

544

通过抑制依赖于RIP3的TLR4/ MyD88/ NF- kB信号通路,恩帕格利弗洛辛可以缓解多克索鲁比引起的心肌损伤.

Yunfei Zou1, Junyi Li2, Changwen Xu2

  • 1Department of Cardiology, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, China.

Biochemical pharmacology
|August 24, 2025
PubMed
概括

通过阻断RIP3信号通路,减少炎症和细胞死亡,保护心脏免受化疗损伤. 这一发现为预防多克索鲁引起的心脏毒性提供了新的希望.

关键词:
多克索鲁比辛恩帕格利弗洛辛心肌损伤在RIP3TLR4/MyD88/NF-κB信号通道

更多相关视频

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
08:15

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Published on: May 10, 2024

654
A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
08:09

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish

Published on: June 7, 2018

9.9K

相关实验视频

Last Updated: Sep 10, 2025

Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation
09:53

Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation

Published on: January 10, 2025

544
Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
08:15

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Published on: May 10, 2024

654
A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
08:09

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish

Published on: June 7, 2018

9.9K

科学领域:

  • 心脏病学
  • 药理学
  • 分子生物学

背景情况:

  • 多克索鲁比辛 (DOX) 化疗导致剂量依赖的心脏毒性,限制了其使用.
  • 与受体相互作用的蛋白激酶3 (RIP3) 和TLR4/MyD88/NF-κB通路与DOX诱导的心脏损伤有关.
  • 作为SGLT2抑制剂的empagliflozin显示出潜在的独立于降血糖的心脏保护作用.

研究的目的:

  • 调查empagliflozin在DOX引起的心肌损伤中的心脏保护作用.
  • 阐明RIP3介导信号在empagliflozin作用中的机械作用.

主要方法:

  • 使用DOX诱导的心脏毒性和H9C2心肌细胞的小鼠模型.
  • 评估心脏功能障碍,组织病理损伤,氧化应激和分子信号通路.
  • 在实验室中操纵RIP3表达以确认其作用.

主要成果:

  • 恩帕格利弗洛辛显著减轻了DOX引起的心脏功能障碍,损伤和氧化应激.
  • DOX上调了RIP3并激活了TLR4/MyD88/NF-κB通路,增加了细胞亡和铁亡.
  • 恩帕格利弗洛辛逆转了这些分子变化;RIP3过度表达恶化了DOX效应,而恩帕格利弗洛辛则减轻了这种效应.

结论:

  • 通过抑制依赖于RIP3的TLR4/ MyD88/ NF- kB激活,保护Empagliflozin免受DOX诱导的心肌损伤.
  • 这种机制减少了细胞死亡,提供了心脏保护.
  • RIP3被确定为DOX诱导心肌病的潜在治疗标.